Alterity Financial Statements From 2010 to 2026

Alterity Therapeutics Balance Sheet		Trends
Current Value Last Year Historical Average  10 Year Trend Total Assets 55.6 M 52.9 M 29.1 M Slightly volatile Cash 40 M 38.1 M 22.4 M Slightly volatile Cash And Short Term Investments 49.1 M 46.8 M 23.8 M Slightly volatile Common Stock Shares Outstanding 12.9 M 12.3 M 3.6 M Slightly volatile Liabilities And Stockholders Equity 55.6 M 52.9 M 29.1 M Slightly volatile Total Liabilities 2.6 M 4.2 M 3.2 M Slightly volatile Total Current Assets 55.4 M 52.8 M 29 M Slightly volatile Common Stock 317.5 M 302.4 M 174 M Slightly volatile Other Current Liabilities 1.7 M 3.4 M 2.2 M Slightly volatile Total Current Liabilities 2.8 M 4.1 M 3.2 M Slightly volatile Property Plant And Equipment Net 108.5 K 178.4 K 104.5 K Slightly volatile Accounts Payable 1 M 619 K 898.3 K Slightly volatile Non Current Assets Total 132.7 K 139.7 K 922.5 K Slightly volatile Net Receivables 2.5 M 4.5 M 3.5 M Slightly volatile Other Current Assets 750.1 K 1.5 M 991 K Slightly volatile Common Stock Total Equity 128.1 M 227.1 M 153 M Slightly volatile Non Current Liabilities Total 68.4 K 79.7 K 36.8 K Slightly volatile Property Plant And Equipment Gross 174.3 K 178.4 K 191.8 K Slightly volatile Other Liabilities 15 K 22.4 K 12 K Slightly volatile Net Tangible Assets 24.6 M 26.2 M 21.7 M Slightly volatile Property Plant Equipment 324.7 K 309.2 K 130.9 K Slightly volatile Net Invested Capital 25.5 M 48.8 M 25 M Slightly volatile Net Working Capital 25.4 M 48.7 M 24.9 M Slightly volatile Capital Stock 224.5 M 302.4 M 188.7 M Slightly volatile
Alterity Therapeutics Income Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Other Operating Expenses 24.2 M 23 M 13.9 M Slightly volatile Total Revenue 6.6 M 6.3 M 2.2 M Slightly volatile Research Development 8.5 M 16.6 M 10.8 M Slightly volatile Depreciation And Amortization 24.2 K 25.5 K 98.2 K Slightly volatile Selling General Administrative 3.7 M 4.9 M 4.4 M Pretty Stable Selling And Marketing Expenses 8.3 K 8.7 K 103 K Slightly volatile Interest Income 500.3 K 401.7 K 1.6 M Slightly volatile Net Interest Income 538.9 K 513.2 K 180 K Slightly volatile Reconciled Depreciation 86.1 K 160.7 K 63.5 K Slightly volatile
Alterity Therapeutics Cash Flow Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Begin Period Cash Flow 17.4 M 14.5 M 18.6 M Pretty Stable Depreciation 194 K 125.7 K 135.6 K Pretty Stable End Period Cash Flow 40 M 38.1 M 22.6 M Slightly volatile Issuance Of Capital Stock 51.4 M 49 M 19.5 M Slightly volatile
Financial Ratios		Trends
Current Value Last Year Historical Average  10 Year Trend Price To Sales Ratio 10.06 10.59 153 Slightly volatile Days Sales Outstanding 226 238 4.2 K Slightly volatile Average Payables 705.4 K 503.7 K 871.2 K Slightly volatile Capex To Depreciation 0.0332 0.0349 0.6463 Slightly volatile Sales General And Administrative To Revenue 1.1 1.16 10.8094 Slightly volatile Research And Ddevelopement To Revenue 2.26 2.38 28.1295 Slightly volatile Capex To Revenue 0.0016 0.0016 0.0737 Slightly volatile Cash Per Share 0.0069 0.0073 0.0251 Slightly volatile Income Quality 0.75 0.85 1.0122 Pretty Stable Intangibles To Total Assets 0.3 0.32 0.3107 Slightly volatile Net Debt To EBITDA 2.17 2.59 1.7865 Very volatile Current Ratio 6.38 11.68 8.6181 Very volatile Receivables Turnover 1.51 1.59 1.6176 Slightly volatile Debt To Equity 0.004 0.0042 0.0125 Slightly volatile Capex Per Share 0.0 0.0 1.0E-4 Slightly volatile Average Receivables 6 M 5.7 M 4.4 M Slightly volatile Revenue Per Share 9.0E-4 0.001 0.0011 Pretty Stable Interest Debt Per Share 0.0 0.0 3.0E-4 Slightly volatile Debt To Assets 0.0037 0.0039 0.0099 Slightly volatile Operating Cycle 226 238 5.4 K Slightly volatile Ebt Per Ebit 1.13 0.95 0.9616 Very volatile Total Debt To Capitalization 0.004 0.0042 0.012 Slightly volatile Debt Equity Ratio 0.004 0.0042 0.0125 Slightly volatile Quick Ratio 6.34 11.68 8.5714 Very volatile Net Income Per E B T 0.8 0.91 0.9705 Slightly volatile Cash Ratio 7.48 10.79 7.126 Very volatile Days Of Sales Outstanding 226 238 4.2 K Slightly volatile Free Cash Flow Operating Cash Flow Ratio 1.11 1.15 1.0188 Slightly volatile Fixed Asset Turnover 33.12 31.55 17.0314 Slightly volatile Debt Ratio 0.0037 0.0039 0.0099 Slightly volatile Price Sales Ratio 10.06 10.59 153 Slightly volatile Asset Turnover 0.11 0.1182 0.0676 Slightly volatile
Alterity Therapeutics Valuation Data		Trends
Current Value Last Year Historical Average  10 Year Trend Market Cap 47.5 M 73.6 M 45 M Pretty Stable

Alterity Fundamental Market Drivers

About Alterity Therapeutics Financial Statements

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Alterity Therapeutics is a strong investment it is important to analyze Alterity Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Alterity Therapeutics' future performance. For an informed investment choice regarding Alterity Stock, refer to the following important reports:

How To Invest In Alterity Details

Is Alterity Stock a good investment? Details

What is Alterity Therapeutics' Net Worth? Details

Largest Biotechnology Companies View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies View

Altman Z Score Details

Piotroski F Score Details

Beneish M Score Details

Financial Analysis Details

Buy or Sell Advice Details

Earnings Projections Details